This brand name is authorized in Austria, Cyprus, Estonia, Spain, Croatia, Ireland, Lithuania, Netherlands, Poland
The drug CONBRIZA contains one active pharmaceutical ingredient (API):
|
1
Bazedoxifene
UNII J70472UD3D - BAZEDOXIFENE ACETATE
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| CONBRIZA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03XC02 | Bazedoxifene | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03X Other sex hormones and modulators of the genital system → G03XC Selective estrogen receptor modulators |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1413863, 1413874, 1413885, 1413896, 1523696 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 09511001 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 18010 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1037192, 1037193, 1037194, 1037195, 1063650 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 90638 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100218813 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
